COMMUNIQUÉS West-GlobeNewswire

Palvella Therapeutics Announces $10 Million in Funding from Ligand Pharmaceuticals to Accelerate PTX-022 through Phase 2/3 Clinical Study in Pachyonychia Congenita
18/12/2018
Fast Track-Designated Program Commencing Phase 2/3 Study in Q1 2019 Wayne, PA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and [...]
Delcath Announces 4th Independent Safety Review of Registration Trial Data for Metastatic Ocular Melanoma: Recommended Continuation with no Trial Modification
18/12/2018
Trial Continues on Scheduled Path with Expected Completion of Enrollment by June 2019 NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the [...]
VBI Vaccines Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriter’s Option to Purchase Additional Shares for Aggregate Gross Proceeds of $42.9 Million
18/12/2018
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
HealthLynked Announces Agreement with Availity, the Nation’s Largest Health Benefits Network, to Deliver HealthLynked Members Real-time Benefit Information
18/12/2018
NAPLES, Fla., Dec. 18, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced the company has entered into a master trading partner agreement with Availity, a leader in real-time information [...]
InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems
18/12/2018
Analysis includes clinical studies incorporating the Company’s MicroNet™-covered stent, the CGuard™ Embolic Prevention System (EPS) TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: [...]
Progressive Care Inc. Garners News Coverage in Leading Financial Publications, Yahoo Finance and Benzinga on Its Efforts to End the Opioid Crisis
18/12/2018
MIAMI, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered news coverage in leading financial [...]
Sport Endurance Announces Investment in Nutritional Pet Food Company, TruPet
18/12/2018
BROOKLYN, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”), announced today that it has made a $2.2 million investment in TruPet LLC (“TruPet”), the parent company of TruDog, a [...]
Radient Technologies Inc. Announces Commencement of Trading on the OTCQX, Best Market in the United States
18/12/2018
EDMONTON, Alberta, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that its common shares commenced trading today on the [...]
OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control
18/12/2018
GAITHERSBURG, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced that it has provided the final report for completion of the contract from the Centers for Disease Control and Prevention ( [...]
ProMIS Neurosciences to Present at Sachs Associates Neuroscience Innovation Forum and China Focus@JPMWeek
18/12/2018
ProMIS to showcase its Alzheimer’s, Parkinson’s and ALS programs at notable biotech investor events TORONTO and CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a [...]
Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board
18/12/2018
SHANGHAI, China and NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of immunotherapies for [...]
Terveystalo Plc: Disclosure under chapter 9, section 10 of the securities market act
18/12/2018
Terveystalo Plc Stock Exchange Release 18 December 2018 at 14:15 EET Terveystalo Plc has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Ilmarinen Mutual [...]
Holding(s) in Company
18/12/2018
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
Resonant Inc. Signs New License Agreement with a Leading Chinese Optoelectronics Company that has Targeted the RFFE Market for Expanded Growth
18/12/2018
New customer selects Resonant to shorten time to market for a high performance quadplexer design Becoming second customer to leverage Resonant standard library-based quadplexer filter design GOLETA, Calif., Dec. 18, [...]
AVROBIO, Inc. Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
18/12/2018
CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ: AVRO), (“The Company”) a Phase 2 clinical-stage gene therapy company, today announced the grant of non-qualified stock options to purchase 293, [...]
Axsome Therapeutics to Present at Biotech Showcase 2019
18/12/2018
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires
18/12/2018
Birgitte Volck, M.D., Ph.D., is appointed President of Research and Development and will oversee clinical, regulatory, research and manufacturing CAMBRIDGE, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . ( [...]
Tonix Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
18/12/2018
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat [...]
Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board
18/12/2018
- Seasoned biotech executive and accomplished scientific leader with broad experience from early-stage company development to managing publicly traded entities - GERMANTOWN, Md., Dec. 18, 2018 (GLOBE NEWSWIRE) -- [...]

Pages